This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Feb;172(2):319-20.

doi: 10.1111/bjd.13600.

Evidence and nuances of propranolol safety

Affiliations

Affiliation

¹ Department of Dermatology, Division of Pediatric Dermatology, Johns Hopkins University School of Medicine, 200 North Wolfe Street, Unit 2107, Baltimore, 21287, MD, U.S.A. kateputtgen@jhmi.edu.

PMID: 25660680
DOI: 10.1111/bjd.13600

Comment

Evidence and nuances of propranolol safety

K B Püttgen. Br J Dermatol. 2015 Feb.

. 2015 Feb;172(2):319-20.

doi: 10.1111/bjd.13600.

Author

Affiliation

¹ Department of Dermatology, Division of Pediatric Dermatology, Johns Hopkins University School of Medicine, 200 North Wolfe Street, Unit 2107, Baltimore, 21287, MD, U.S.A. kateputtgen@jhmi.edu.

PMID: 25660680
DOI: 10.1111/bjd.13600

No abstract available

PubMed Disclaimer

Comment on

Safety profile of a divided dose of propranolol for heart rate in children with infantile haemangioma during 16 weeks of treatment.
Song H, Shi H, Zhang X, Wang J, Yu Y, Chen W, Zhou H. Song H, et al. Br J Dermatol. 2015 Feb;172(2):444-9. doi: 10.1111/bjd.13250. Epub 2014 Dec 7. Br J Dermatol. 2015. PMID: 25041341

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information